CPA
OGN icon

Capital Performance Advisors’s Organon & Co OGN Stock Holding History

Capital Performance Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-360
Closed -$6.89K – 1865
2024
Q3 		$6.89K Buy
+360
New +$7.46K ﹤0.01% 976

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Performance Advisors's OGN Position: Q4 2024 in Review

Capital Performance Advisors sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 360 shares — an estimated $6.89K sold.

Capital Performance Advisors first reported a position in OGN in Q3 2024 and held it in 1 quarter. The position peaked at $6.89K in Q3 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Capital Performance Advisors reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 360 Organon & Co shares in Q4 2024, an estimated $6.89K.
  • Capital Performance Advisors first reported a position in Organon & Co in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Organon & Co position peaked at $6.89K in Q3 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.